Evidence map›Paper›PMID 37506243›Full record

ArticleNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2023

Patterns of Premium and Nonpremium Cigar Use in the United States: Findings from Wave 6 (2021) of the Population Assessment of Tobacco and Health Study.

Kathryn C Edwards, Michael J Halenar, Cristine D Delnevo, Andrea C Villanti, Maansi Bansal-Travers, Richard O'Connor, Arseima Y Del Valle-Pinero, MeLisa R Creamer, Elisabeth A Donaldson, Hoda T Hammad and 8 more

Open access · hybridAbstract read
In one paragraph

Article in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The Public Health Impact of a Ban on Flavored Cigars: A Decision-Theoretic Policy Framework.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Article
  6. Article
  7. Article
  8. Regulatory Research Advances on Premium Cigars.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 1 country.

Kathryn C EdwardsBehavioral Health and Health Policy, Westat, Rockville, MD, USA.ORCID 0000-0002-0645-1705
Michael J HalenarBehavioral Health and Health Policy, Westat, Rockville, MD, USA.ORCID 0000-0002-8703-3811
Cristine D DelnevoRutgers Center for Tobacco Studies, Rutgers University, New Brunswick, NJ, USA.ORCID 0000-0001-9597-4307
Andrea C VillantiDepartment of Health Behavior, Society and Policy, Rutgers University, New Brunswick, NJ, USA.ORCID 0000-0003-3104-966X
Maansi Bansal-TraversDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.ORCID 0000-0002-7944-3570
Richard O'ConnorDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Arseima Y Del Valle-PineroCenter for Tobacco Products, Food and Drug Administration, Silver Spring, MD, USA.
MeLisa R CreamerDivision of Epidemiology, Services and Prevention, National Institute on Drug Abuse, Bethesda, MD, USA.
Elisabeth A DonaldsonCenter for Tobacco Products, Food and Drug Administration, Silver Spring, MD, USA.
Hoda T HammadCenter for Tobacco Products, Food and Drug Administration, Silver Spring, MD, USA.
Lisa LagasseCenter for Tobacco Products, Food and Drug Administration, Silver Spring, MD, USA.
Andrew Anesetti-RothermelCenter for Tobacco Products, Food and Drug Administration, Silver Spring, MD, USA.
Kristie A TaylorBehavioral Health and Health Policy, Westat, Rockville, MD, USA.
Heather L KimmelDivision of Epidemiology, Services and Prevention, National Institute on Drug Abuse, Bethesda, MD, USA.ORCID 0000-0001-8278-0095
Wilson ComptonNational Institute on Drug Abuse, Bethesda, MD, USA.ORCID 0000-0003-3108-5118
Yu-Ching ChengCenter for Tobacco Products, Food and Drug Administration, Silver Spring, MD, USA.
Bridget K AmbroseCenter for Tobacco Products, Food and Drug Administration, Silver Spring, MD, USA.
Andrew HylandDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
National Institute on Drug Abuse · USRoswell Park Comprehensive Cancer Center · USWestat (United States) · USRutgers, The State University of New Jersey · US

Funding

NIDA NIH HHS HHSN271201100027CNIDA NIH HHS HHSN271201600001C
6 · The paper itself

Abstract

introductionUnderstanding the characteristics of premium cigar use patterns is essential for minimizing public health harms. Typically, premium cigars are handmade, larger, more expensive, and without the characterizing flavors that are present in other cigar types: Nonpremium traditional cigars, cigarillos, and filtered cigars. AIMS AND

methodsSelf-reported brand and price data were used from Wave 6 of the Population Assessment of Tobacco and Health (PATH) Study to define and estimate premium versus nonpremium cigar use among U.S. adults, as well as to explore cigar smoking patterns, purchasing behavior, and reasons for use by cigar type.

resultsIn 2021, 0.9% (95% CI = 0.7-1.0) of adults were premium cigar users, compared to 0.4% of nonpremium traditional cigar users (95% CI = 0.3-0.5), 1.1% of cigarillo users (95% CI = 1.0-1.2), and 0.6% filtered cigar users (95% CI = 0.5-0.7). Premium cigar users were overwhelmingly male (97.7%), and 35.8% were aged ≥55 years. The average premium cigar price/stick was $8.67, $5.50-7.00 more than other cigar types. Compared to other cigar types, significantly fewer premium cigar users had a regular brand with a flavor other than tobacco (~15% vs. 38%-53%). Though flavors remained the top reason for premium cigar use, they were less likely to endorse flavors as a reason for use than other cigar users (~40% vs. 68-74%). Premium cigar users had a lower prevalence (aRR: 0.37, 95% CI = 0.25-0.55) of dual use of cigars and cigarettes.

conclusionsAlthough <1% of U.S. adults use premium cigars, their use and purchasing characteristics continue to differ from other cigar types, highlighting the importance of capturing data specific to premium cigar use. IMPLICATIONS: This manuscript extends previous research from the National Academies of Science, Engineering, and Medicine report, "Premium cigars: Patterns of use, marketing, and health effects" by utilizing the most recent PATH Study data (Wave 6) to examine patterns of cigar use, including purchasing behavior and reasons for use, by cigar type (eg, premium traditional cigars, nonpremium traditional cigars, cigarillos, and filtered cigars). The findings support continued research on patterns of premium cigar use, which differ from use patterns of other cigar types.

Indexed as

Cigar SmokingTobacco ProductsAdolescentAdultFemaleHumansMaleMiddle AgedSelf ReportSmokingUnited StatesYoung Adult

Identifiers

PMID37506243
PMCPMC10885408
OpenAlexW4385329554

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.